MetLife Investment Management’s Cintas CTAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5M Sell
91,208
-3,794
-4% -$656K 0.07% 268
2026
Q1
$16.1M Sell
95,002
-3,498
-4% -$671K 0.08% 231
2025
Q4
$18.5M Sell
98,500
-2,788
-3% -$525K 0.09% 187
2025
Q3
$20.8M Sell
101,288
-1,825
-2% -$390K 0.1% 156
2025
Q2
$23M Sell
103,113
-311
-0.3% -$66.9K 0.14% 122
2025
Q1
$21.3M Sell
103,424
-1,825
-2% -$364K 0.11% 140
2024
Q4
$19.2M Buy
105,249
+1,163
+1% +$245K 0.1% 145
2024
Q3
$21.4M Sell
104,086
-3,170
-3% -$612K 0.12% 131
2024
Q2
$18.8M Buy
107,256
+13,764
+15% +$2.35M 0.11% 136
2024
Q1
$16.1M Sell
93,492
-3,292
-3% -$507K 0.11% 146
2023
Q4
$14.6M Sell
96,784
-1,648
-2% -$221K 0.11% 147
2023
Q3
$11.8M Sell
98,432
-2,200
-2% -$274K 0.09% 169
2023
Q2
$12.5M Sell
100,632
-1,444
-1% -$169K 0.09% 167
2023
Q1
$11.8M Sell
102,076
-972
-0.9% -$107K 0.08% 184
2022
Q4
$11.6M Sell
103,048
-1,728
-2% -$187K 0.09% 178
2022
Q3
$10.2M Sell
104,776
-2,376
-2% -$243K 0.08% 188
2022
Q2
$10M Sell
107,152
-3,392
-3% -$331K 0.08% 198
2022
Q1
$11.8M Buy
110,544
+32,860
+42% +$3.2M 0.08% 201
2021
Q4
$8.61M Sell
77,684
-1,392
-2% -$150K 0.07% 227
2021
Q3
$7.53M Sell
79,076
-2,764
-3% -$270K 0.07% 237
2021
Q2
$7.82M Sell
81,840
-2,256
-3% -$200K 0.07% 237
2021
Q1
$7.18M Sell
84,096
-1,280
-1% -$108K 0.07% 264
2020
Q4
$7.54M Sell
85,376
-2,800
-3% -$243K 0.07% 235
2020
Q3
$7.34M Buy
88,176
+4
+0% +$308 0.08% 209
2020
Q2
$5.87M Buy
88,172
+1,732
+2% +$100K 0.07% 259
2020
Q1
$3.74M Sell
86,440
-2,644
-3% -$173K 0.05% 344
2019
Q4
$5.99M Sell
89,084
-1,280
-1% -$84.2K 0.06% 280
2019
Q3
$6.06M Sell
90,364
-3,028
-3% -$194K 0.07% 273
2019
Q2
$5.54M Sell
93,392
-2,900
-3% -$160K 0.06% 305
2019
Q1
$4.87M Sell
96,292
-2,760
-3% -$134K 0.05% 350
2018
Q4
$4.16M Sell
99,052
-1,128
-1% -$50.4K 0.05% 358
2018
Q3
$4.95M Sell
100,180
-1,608
-2% -$83.1K 0.05% 360
2018
Q2
$4.71M Sell
101,788
-2,044
-2% -$92K 0.06% 332
2018
Q1
$4.43M Sell
103,832
-2,736
-3% -$114K 0.05% 374
2017
Q4
$4.15M Buy
+106,568
New +$4.05M 0.05% 439

Other funds holding CTAS

MetLife Investment Management's CTAS Position: Q2 2026 in Review

MetLife Investment Management reduced its Cintas (CTAS) stake by 4% in Q2 2026, selling an estimated $656K and leaving 91,208 shares worth $15.5M. The position accounts for 0.07% of the portfolio, ranked #268.

MetLife Investment Management first reported a position in CTAS in Q4 2017 and has held it in 35 quarters since. The position peaked at $23M in Q2 2025. 1,420 funds tracked by Wall St. Rank hold CTAS as of Q2 2026.

  • MetLife Investment Management held 91,208 shares of Cintas worth $15.5M as of Q2 2026.
  • MetLife Investment Management sold 3,794 Cintas shares in Q2 2026, an estimated $656K.
  • Cintas made up 0.07% of MetLife Investment Management's portfolio in Q2 2026, its #268 holding.
  • MetLife Investment Management first reported a position in Cintas in Q4 2017 and has held it in 35 quarters since.
  • MetLife Investment Management's Cintas position peaked at $23M in Q2 2025.
  • 1,420 funds tracked by Wall St. Rank held Cintas as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.